DIN 02242815 — SIMULECT 20 MG
SIMULECT is a powder for solution of Basiliximab marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Basiliximab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02242815
- Brand name
- SIMULECT
- Active ingredient
- Basiliximab
- Strength
- 20 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Interleukin-2 receptor antagonist (monoclonal antibody immunosuppressant)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.